Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Crucell and Isu Abxis sign research license agreement
Star technology is a production technology that is useful for the production of recombinant human antibodies and proteins. It is said to be effective for production of antibodies
Star technology is a production technology that is useful for the production of recombinant human antibodies and proteins. It is said to be effective for production of antibodies
The company intends to grant the underwriters a 30-day option to purchase up to an additional 1.5 million shares of its common stock to cover over-allotments. All of
The subject matter includes several variations of the expression vector system for inducing cells to produce specifically designed single strands of DNA (ssDNA) which may be used in
The expression level of these proteins may help predict how these patients will respond to therapy. A business unit of Genzyme Corporation, Genzyme Genetics’s relationship with Moffitt is
Data from this randomized, multi-center, placebo-controlled withdrawal trial showed that XP13512 (GSK1838262) was generally well-tolerated and that there was a statistically significant difference between the percentage of patients
Under the terms of the agreement, Strativa will have exclusive marketing, sales and distribution rights to Onconase for the treatment of cancer in the US and its territories.
The study will evaluate CGT-2168, which is a combination of clopidogrel (currently marketed by Bristol-Myers Squibb and Sanofi-Aventis as Plavix) and a gastroprotectant (omeprazole) in a single pill.
Under the terms of the agreement, Invitrogen and PamGene will co-market Invitrogen’s nuclear hormone receptor proteins and Lanthascreen assay technology with PamGene’s portfolio of microarray-based nuclear hormone receptor
In this second study, administration of A-002 lowered both secretory phospholipase A2 (sPLA2) and low density lipoprotein cholesterol (LDL-C) levels confirming the positive effects of A-002 treatment seen
In the independently conducted, large-scale, randomized, single-blind study by J-WIND in 603 patients, carperitide, when administered to acute myocardial infarction (AMI) patients after reperfusion treatment, was associated with